Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

PrimedRPA: primer design for recombinase polymerase amplification assays.

Higgins M, Ravenhall M, Ward D, Phelan J, Ibrahim A, Forrest MS, Clark TG, Campino S.

Bioinformatics. 2019 Feb 15;35(4):682-684. doi: 10.1093/bioinformatics/bty701.

2.

Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation.

Harding-Esch EM, Fuller SS, Chow SC, Nori AV, Harrison MA, Parker M, Piepenburg O, Forrest MS, Brooks DG, Patel R, Hay PE, Fearnley N, Pond MJ, Dunbar JK, Butcher PD, Planche T, Lowndes CM, Sadiq ST.

Clin Microbiol Infect. 2019 Mar;25(3):380.e1-380.e7. doi: 10.1016/j.cmi.2018.06.003. Epub 2018 Jun 12.

3.

Duplex recombinase polymerase amplification assays incorporating competitive internal controls for bacterial meningitis detection.

Higgins O, Clancy E, Forrest MS, Piepenburg O, Cormican M, Boo TW, O'Sullivan N, McGuinness C, Cafferty D, Cunney R, Smith TJ.

Anal Biochem. 2018 Apr 1;546:10-16. doi: 10.1016/j.ab.2018.01.016. Epub 2018 Jan 31.

PMID:
29378166
4.

Development of a rapid recombinase polymerase amplification assay for the detection of Streptococcus pneumoniae in whole blood.

Clancy E, Higgins O, Forrest MS, Boo TW, Cormican M, Barry T, Piepenburg O, Smith TJ.

BMC Infect Dis. 2015 Oct 29;15:481. doi: 10.1186/s12879-015-1212-5.

5.

Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification.

Boyle DS, McNerney R, Teng Low H, Leader BT, Pérez-Osorio AC, Meyer JC, O'Sullivan DM, Brooks DG, Piepenburg O, Forrest MS.

PLoS One. 2014 Aug 13;9(8):e103091. doi: 10.1371/journal.pone.0103091. eCollection 2014.

6.

Recombinations in staphylococcal cassette chromosome mec elements compromise the molecular detection of methicillin resistance in Staphylococcus aureus.

Hill-Cawthorne GA, Hudson LO, El Ghany MF, Piepenburg O, Nair M, Dodgson A, Forrest MS, Clark TG, Pain A.

PLoS One. 2014 Jun 27;9(6):e101419. doi: 10.1371/journal.pone.0101419. eCollection 2014.

7.

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Edwards SM, Evans DG, Hope Q, Norman AR, Barbachano Y, Bullock S, Kote-Jarai Z, Meitz J, Falconer A, Osin P, Fisher C, Guy M, Jhavar SG, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Forrest MS, Dearnaley DP, Ardern-Jones AT, Page EC, Easton DF, Eeles RA; UK Genetic Prostate Cancer Study Collaborators and BAUS Section of Oncology.

Br J Cancer. 2010 Sep 7;103(6):918-24. doi: 10.1038/sj.bjc.6605822. Epub 2010 Aug 24.

8.

Data analysis issues for allele-specific expression using Illumina's GoldenGate assay.

Ritchie ME, Forrest MS, Dimas AS, Daelemans C, Dermitzakis ET, Deloukas P, Tavaré S.

BMC Bioinformatics. 2010 May 26;11:280. doi: 10.1186/1471-2105-11-280.

9.

High-throughput analysis of candidate imprinted genes and allele-specific gene expression in the human term placenta.

Daelemans C, Ritchie ME, Smits G, Abu-Amero S, Sudbery IM, Forrest MS, Campino S, Clark TG, Stanier P, Kwiatkowski D, Deloukas P, Dermitzakis ET, Tavaré S, Moore GE, Dunham I.

BMC Genet. 2010 Apr 19;11:25. doi: 10.1186/1471-2156-11-25.

10.

Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms.

McHale CM, Zhang L, Lan Q, Li G, Hubbard AE, Forrest MS, Vermeulen R, Chen J, Shen M, Rappaport SM, Yin S, Smith MT, Rothman N.

Genomics. 2009 Apr;93(4):343-9. doi: 10.1016/j.ygeno.2008.12.006. Epub 2009 Jan 20.

11.

Modifier effects between regulatory and protein-coding variation.

Dimas AS, Stranger BE, Beazley C, Finn RD, Ingle CE, Forrest MS, Ritchie ME, Deloukas P, Tavaré S, Dermitzakis ET.

PLoS Genet. 2008 Oct;4(10):e1000244. doi: 10.1371/journal.pgen.1000244. Epub 2008 Oct 31.

12.

Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.

Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A, Paynter RA, Skibola DR, Agana L, Becker N, Tressler P, Forrest MS, Sankararaman S, Conde L, Holly EA, Smith MT.

PLoS One. 2008 Jun 30;3(7):e2816. doi: 10.1371/journal.pone.0002816.

13.

Population genomics of human gene expression.

Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, Ingle CE, Dunning M, Flicek P, Koller D, Montgomery S, Tavaré S, Deloukas P, Dermitzakis ET.

Nat Genet. 2007 Oct;39(10):1217-24. Epub 2007 Sep 16.

14.

Relative impact of nucleotide and copy number variation on gene expression phenotypes.

Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavaré S, Deloukas P, Hurles ME, Dermitzakis ET.

Science. 2007 Feb 9;315(5813):848-53.

15.

Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.

Lightfoot TJ, Skibola CF, Smith AG, Forrest MS, Adamson PJ, Morgan GJ, Bracci PM, Roman E, Smith MT, Holly EA.

Haematologica. 2006 Sep;91(9):1222-7.

16.

Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.

Forrest MS, Skibola CF, Lightfoot TJ, Bracci PM, Willett EV, Smith MT, Holly EA, Roman E.

Br J Haematol. 2006 Jul;134(2):180-3. Epub 2006 Jun 1.

PMID:
16740140
17.

Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity.

Shen M, Lan Q, Zhang L, Chanock S, Li G, Vermeulen R, Rappaport SM, Guo W, Hayes RB, Linet M, Yin S, Yeager M, Welch R, Forrest MS, Rothman N, Smith MT.

Carcinogenesis. 2006 Oct;27(10):2083-9. Epub 2006 May 25.

PMID:
16728435
18.

Genome-wide associations of gene expression variation in humans.

Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, Hunt S, Kahl B, Antonarakis SE, Tavaré S, Deloukas P, Dermitzakis ET.

PLoS Genet. 2005 Dec;1(6):e78. Epub 2005 Dec 16.

19.

Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene.

Lan Q, Zhang L, Shen M, Smith MT, Li G, Vermeulen R, Rappaport SM, Forrest MS, Hayes RB, Linet M, Dosemeci M, Alter BP, Weinberg RS, Yin S, Yeager M, Welch R, Waidyanatha S, Kim S, Chanock S, Rothman N.

Cancer Res. 2005 Oct 15;65(20):9574-81.

20.

Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk.

Skibola CF, Bracci PM, Paynter RA, Forrest MS, Agana L, Woodage T, Guegler K, Smith MT, Holly EA.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2391-401.

21.

Use of 'Omic' technologies to study humans exposed to benzene.

Smith MT, Vermeulen R, Li G, Zhang L, Lan Q, Hubbard AE, Forrest MS, McHale C, Zhao X, Gunn L, Shen M, Rappaport SM, Yin S, Chanock S, Rothman N.

Chem Biol Interact. 2005 May 30;153-154:123-7. Epub 2005 Apr 19. Review.

PMID:
15935808
22.

Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers.

Forrest MS, Lan Q, Hubbard AE, Zhang L, Vermeulen R, Zhao X, Li G, Wu YY, Shen M, Yin S, Chanock SJ, Rothman N, Smith MT.

Environ Health Perspect. 2005 Jun;113(6):801-7.

23.

Association between hormonal genetic polymorphisms and early-onset prostate cancer.

Forrest MS, Edwards SM, Houlston R, Kote-Jarai Z, Key T, Allen N, Knowles MA, Turner F, Ardern-Jones A, Murkin A, Williams S, Oram R, Bishop DT, Eeles RA; CR-UK/BPG UK prostate cancer study collaborators.

Prostate Cancer Prostatic Dis. 2005;8(1):95-102.

PMID:
15711606
24.

Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma.

Skibola CF, Forrest MS, Coppedé F, Agana L, Hubbard A, Smith MT, Bracci PM, Holly EA.

Blood. 2004 Oct 1;104(7):2155-62. Epub 2004 Jun 15.

PMID:
15198953
25.

High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemia.

Rollinson S, Allan JM, Law GR, Roddam PL, Smith MT, Skibola C, Smith AG, Forrest MS, Sibley K, Higuchi R, Germer S, Morgan GJ.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):795-800.

26.

Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma.

Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, Hegedus C, Smith MT.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):779-86.

27.
28.

No evidence of germline PTEN mutations in familial prostate cancer.

Forrest MS, Edwards SM, Hamoudi RA, Dearnaley DP, Arden-Jones A, Dowe A, Murkin A, Kelly J, Teare MD, Easton DF, Knowles MA, Bishop DT, Eeles RA.

J Med Genet. 2000 Mar;37(3):210-2. No abstract available.

29.

Induction of ovulation with subcutaneous pulsatile gonadotropin-releasing hormone: correlation with body weight and other parameters.

Thomas AK, Mander J, Hale J, Walstab J, Forrest MS.

Fertil Steril. 1989 May;51(5):786-90.

PMID:
2495993
30.

Menstrual pattern and fertility after treatment for anovulatory infertility.

Thomas AK, Forrest MS.

Aust N Z J Obstet Gynaecol. 1983 Feb;23(1):48-50.

PMID:
6575760
31.

Infertility: a review of 291 infertile couples over eight years.

Thomas AK, Forrest MS.

Fertil Steril. 1980 Aug;34(2):106-11.

PMID:
7409228
32.

Depression and autonomic arousal reduction accompanying self-punitive behavior.

Forrest MS, Hokanson JE.

J Abnorm Psychol. 1975 Aug;84(4):346-57. No abstract available.

PMID:
1176711
33.

Availability of avoidance behaviors in modulating vascular-stress responses.

Hokanson JE, DeGood DE, Forrest MS, Brittain TM.

J Pers Soc Psychol. 1971 Jul;19(1):60-8. No abstract available.

PMID:
5105133
34.

Effects of posture and anxiety level on effectiveness of free association.

Kroth JA, Forrest MS.

Psychol Rep. 1969 Dec;25(3):725-6. No abstract available.

PMID:
5398863
35.

Irradiation in the treatment of anovulation.

FORREST MS.

Med J Aust. 1957 Aug 31;44(9):325-6. No abstract available.

PMID:
13476950

Supplemental Content

Loading ...
Support Center